Literature DB >> 1940138

The epidemiology and natural history of infantile spasms.

L D Cowan1, L S Hudson.   

Abstract

Few population-based studies of infantile spasms have been done, and most reports have not included comparison groups. In spite of these limitations, this review attempts to summarize what is known about the distribution, etiology, and natural history of infantile spasms in populations; discusses the limitations of current data; and includes suggestions for further population-based research. Most estimates of the incidence of infantile spasms are between 0.25 and 0.42 per 1000 live births per year. Among children less than 10 years of age, the annual prevalence of infantile spasms is 0.14 to 0.19 per 1000. The peak age at onset of spasms is 4 to 6 months, and there appears to be a slight excess of male cases. The etiology of infantile spasms is unknown for 40% to 50% of affected children. Selected syndromes (eg, Aicardi syndrome, Down syndrome, etc) and inherited disorders (eg, tuberous sclerosis) may account for as many as one third of cases. Other factors, such as intrauterine infection, "birth injury," and head trauma have not been systematically evaluated, and thus, their contribution to the etiology of infantile spasms is uncertain. Areas for future etiologic research include controlled studies of immunologic factors and in utero and postnatal infections and further exploration of the interrelationship between infantile spasms and Lennox-Gastaut syndrome.

Entities:  

Mesh:

Year:  1991        PMID: 1940138     DOI: 10.1177/088307389100600412

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  26 in total

1.  Meaningful Results in a Jiffy - A PERC of Multicenter Collaborations.

Authors:  M Scott Perry
Journal:  Epilepsy Curr       Date:  2016 Sep-Oct       Impact factor: 7.500

2.  Knowledge, Attitude and Practice (KAP) Study of Pediatricians on Infantile Spasms.

Authors:  Vamsi Krishna Vaddi; Jitendra Kumar Sahu; Sumeet R Dhawan; Renu Suthar; Naveen Sankhyan
Journal:  Indian J Pediatr       Date:  2018-02-14       Impact factor: 1.967

Review 3.  Infantile spasms.

Authors:  R E Appleton
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

Review 4.  Infantile Spasms-Have We Made Progress?

Authors:  Sarah Aminoff Kelley; Kelly G Knupp
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-19       Impact factor: 5.081

5.  A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy.

Authors:  Katherine B Howell; Stefanie Eggers; Kim Dalziel; Jessica Riseley; Simone Mandelstam; Candace T Myers; Jacinta M McMahon; Amy Schneider; Gemma L Carvill; Heather C Mefford; Ingrid E Scheffer; A Simon Harvey
Journal:  Epilepsia       Date:  2018-05-11       Impact factor: 5.864

6.  Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms.

Authors:  Jason T Lerner; Noriko Salamon; Raman Sankar
Journal:  Neuropsychiatr Dis Treat       Date:  2010-11-08       Impact factor: 2.570

7.  Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.

Authors:  Kelly G Knupp; Erin Leister; Jason Coryell; Katherine C Nickels; Nicole Ryan; Elizabeth Juarez-Colunga; William D Gaillard; John R Mytinger; Anne T Berg; John Millichap; Douglas R Nordli; Sucheta Joshi; Renée A Shellhaas; Tobias Loddenkemper; Dennis Dlugos; Elaine Wirrell; Joseph Sullivan; Adam L Hartman; Eric H Kossoff; Zachary M Grinspan; Lorie Hamikawa
Journal:  Epilepsia       Date:  2016-09-12       Impact factor: 5.864

Review 8.  Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis.

Authors:  T Z Baram
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

9.  Clinical profile of infants with hypsarrhythmia.

Authors:  Wael Hayel Khreisat
Journal:  Acta Inform Med       Date:  2011-09

Review 10.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.